Abrocitinib
67 interactions 47 explained in plain English 118 cited referencesAbrocitinib is used to treat moderate to severe eczema (atopic dermatitis; a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in adults and children 12 years of age and older who cannot use other medications for their condition or whose eczema has not responded to other… Read the full Abrocitinib drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Moderate
Abrocitinib Sparsentan Filspari Explained Reduced CYP2C19/CYP2C9 substrate exposure and reduced efficacy of CYP2C19/CYP2C9 substrate Details Abrocitinib Tenofovir Alafenamide Explained Increased tenofovir alafenamide exposure and an increased risk of tenofovir alafenamide-related adverse effects DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist